Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study

Journal of Crohn's & Colitis
C CoutzacD Laharie

Abstract

Anti-tumour necrosis factor [TNF] agents have dramatically improved the prognosis of inflammatory bowel disease [IBD]. However, despite their good safety profile, use of these agents may lead to paradoxical manifestations involving skin or joints. Pathogenesis of such side effects is poorly understood and may involve anti-TNF pharmacokinetics. The aim of the present study was to look for an association between infliximab trough levels [ITL] and cutaneous [CPM] or rheumatological [RPM] paradoxical manifestations. IBD patients receiving infliximab as maintenance therapy were included in a cross-sectional prospective monocentre study. At inclusion, patients had an ITL measurement [LISA-TRACKER®, Biomedical Diagnostics BMD] and were assessed for paradoxical manifestations: a CPM was defined by new onset or exacerbation of pre-existing psoriasis lesions during IFX therapy, and an RPM by new onset of severe poly-arthralgia during IFX therapy. Among the 121 patients included [69 female; median age: 38.9 years; 92 with Crohn's disease], 7% had CPM and 8% RPM. Median ITL values were 5.87 [range: 0.52-19.53] µg/ml in patients with CPM and 1.90 [0.00-13.5] µg/ml in those with RPM, as compared respectively with 5.12 [0.00-49.12] µg/ml in p...Continue Reading

References

Mar 8, 1980·Lancet·R F Harvey, J M Bradshaw
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Feb 27, 2004·The New England Journal of Medicine·Bruce E SandsSander J van Deventer
Sep 25, 2004·Journal of the American Academy of Dermatology·Alice B GottliebAlan Menter
Jul 7, 2005·The Journal of Experimental Medicine·Frank O NestleMichel Gilliet
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
Jun 14, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Laurent Peyrin-BirouletJean-Frédéric Colombel
Oct 14, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Sarah CaspersenUNKNOWN Danish Crohn Colitis Database
Oct 17, 2008·The Journal of Dermatological Treatment·Justin M KoJoseph F Kerbleski
Jan 30, 2010·Annales de dermatologie et de vénéréologie·M ViguierF Aubin
Jun 11, 2010·Journal of Neurogastroenterology and Motility·Su Youn Nam
Aug 24, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jean-François RahierUNKNOWN Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID)
Dec 3, 2010·Journal of Crohn's & Colitis·Gert Van AsscheUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Dec 3, 2010·Journal of Crohn's & Colitis·A DignassUNKNOWN European Crohn's and Colitis Organisation (ECCO)
May 16, 2012·Gastroenterology·Millie D LongMichael D Kappelman
Jul 4, 2012·Nature Reviews. Gastroenterology & Hepatology·Isabelle Cleynen, Séverine Vermeire
Feb 24, 2015·Canadian Journal of Gastroenterology & Hepatology·Vivian HuangRichard N Fedorak

❮ Previous
Next ❯

Citations

Jan 23, 2016·Expert Opinion on Drug Safety·Konstantinos PapamichaelLaurent Peyrin-Biroulet
Sep 10, 2015·Journal of Crohn's & Colitis·Niels Vande Casteele, Séverine Vermeire
Jan 25, 2017·Joint, Bone, Spine : Revue Du Rhumatisme·Maxime SondagDaniel Wendling
Feb 28, 2017·Joint, Bone, Spine : Revue Du Rhumatisme·Daniel WendlingClément Prati
Aug 18, 2018·Expert Review of Clinical Immunology·Carla FeliceAlessandro Armuzzi
Oct 20, 2019·Digestive Diseases and Sciences·Maria T Abreu
Feb 6, 2016·Current Treatment Options in Gastroenterology·Frank I Scott, Gary R Lichtenstein
Apr 12, 2017·Current Gastroenterology Reports·Christopher Sheasgreen, Geoffrey C Nguyen
May 31, 2019·Scandinavian Journal of Gastroenterology·Neeraj NarulaJohn K Marshall
Apr 17, 2020·International Journal of Colorectal Disease·Asaf LevartovskyUri Kopylov
Feb 7, 2017·Alimentary Pharmacology & Therapeutics·S Van SteenbergenM Ferrante
Dec 7, 2018·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Lieven PouillonLaurent Peyrin-Biroulet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2021 Meta ULC. All rights reserved